{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:36:51Z","timestamp":1785731811453,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sentinel lymph node biopsy (SLNB) is performed less often for older patients with melanoma. We investigated the association of SLNB and melanoma-specific survival (MSS) in the elderly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed the Surveillance, Epidemiology, and End Results (SEER: 2010\u20132019) for patients \u2265\u00a070 years with cT2-4N0M0 melanoma. We used multivariable Cox proportional hazard models to evaluate the impact of SLNB performance and SLN status on MSS at increasing age cutoffs. In addition, we evaluated the association of different factors with SLNB performance using multivariable logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 11,548 patients. Sentinel lymph node biopsy occurred in 6754 (58.5%) patients, 1050 (15.5%) of whom had a positive SLN. On adjusted SEER analysis, a negative SLN was independently associated with improved MSS (overall hazard ratio [HR] 0.59, 95% confidence interval [CI] 0.63\u20130.67) for patients up to 87 years old. Positive SLNB was independently associated with inferior MSS (HR 1.71, 95% CI 1.93\u20131.98). Increasing age groups were significantly associated with decreased SLNB performance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sentinel lymph node biopsy is associated with cancer-specific survival and adds prognostic information for elderly patients with melanoma. Sentinel lymph node biopsy performance should not be eliminated in elderly patients based on age alone, unless justified by poor performance status, patient preference, or other surgical contraindications. Decreased SLNB performance with increasing age in our cohort may indicate a missed therapeutic opportunity in the care of elderly patients with melanoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-15684-0","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:01:49Z","timestamp":1721685709000},"page":"8230-8239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Utility of Sentinel Lymph Node Biopsy in Elderly Patients with Melanoma"],"prefix":"10.1245","volume":"31","author":[{"given":"Hanna","family":"Kakish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen A.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Doh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Ammori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Mangla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-8028","authenticated-orcid":false,"given":"Luke D.","family":"Rothermel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"15684_CR1","unstructured":"National Comprehensive Cancer Network. Melanoma (Version3.2022).www.nccn.org\/patients. Accessed 1 Oct 2022."},{"issue":"1","key":"15684_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","volume":"156","author":"KG Paulson","year":"2020","unstructured":"Paulson KG, Gupta D, Kim TS, et al. Age-specific incidence of melanoma in the United States. JAMA Dermatol. 2020;156(1):57. https:\/\/doi.org\/10.1001\/jamadermatol.2019.3353.","journal-title":"JAMA Dermatol."},{"issue":"5","key":"15684_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jgo.2018.01.001","volume":"9","author":"MJ Rees","year":"2018","unstructured":"Rees MJ, Liao H, Spillane J, et al. Melanoma in the very elderly, management in patients 85 years of age and over. J Geriatr Oncol. 2018;9(5):488\u201393. https:\/\/doi.org\/10.1016\/j.jgo.2018.01.001.","journal-title":"J Geriatr Oncol."},{"issue":"10","key":"15684_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/bjs.7565","volume":"98","author":"I Koskivuo","year":"2011","unstructured":"Koskivuo I, Hernberg M, Vihinen P, et al. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma. Br J Surg. 2011;98(10):1400\u20137. https:\/\/doi.org\/10.1002\/bjs.7565.","journal-title":"Br J Surg."},{"issue":"7","key":"15684_CR5","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1245\/s10434-015-4538-8","volume":"22","author":"MW Cavanaugh-Hussey","year":"2015","unstructured":"Cavanaugh-Hussey MW, Mu EW, Kang S, Balch CM, Wang T. Older age is associated with a higher incidence of melanoma death but a lower incidence of sentinel lymph node metastasis in the SEER databases (2003\u20132011). Ann Surg Oncol. 2015;22(7):2120\u20136. https:\/\/doi.org\/10.1245\/s10434-015-4538-8.","journal-title":"Ann Surg Oncol."},{"key":"15684_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7150\/jca.2.538","volume":"2","author":"JB Macdonald","year":"2011","unstructured":"Macdonald JB, Dueck AC, Gray RJ, et al. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer. 2011;2:538\u201343. https:\/\/doi.org\/10.7150\/jca.2.538.","journal-title":"J Cancer."},{"key":"15684_CR7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3332\/ecancer.2021.1167","volume":"15","author":"C Featherston","year":"2021","unstructured":"Featherston C, Nardi WS, Tom\u00e9 FR, Quildrian SD. Role of sentinel lymph node biopsy for cutaneous melanoma in elderly patients: preliminary results in a Latin-American population. Ecancermedicalscience. 2021;15:1167. https:\/\/doi.org\/10.3332\/ecancer.2021.1167.","journal-title":"Ecancermedicalscience."},{"issue":"7","key":"15684_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in Melanoma. N Engl J Med. 2014;370(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1310460.","journal-title":"N Engl J Med."},{"issue":"4","key":"15684_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1245\/s10434-018-6348-2","volume":"25","author":"TD Murtha","year":"2018","unstructured":"Murtha TD, Han G, Han D. Predictors for use of sentinel node biopsy and the association with improved survival in melanoma patients who have nodal staging. Ann Surg Oncol. 2018;25(4):903\u201311. https:\/\/doi.org\/10.1245\/s10434-018-6348-2.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"15684_CR10","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1245\/s10434-015-4539-7","volume":"22","author":"MS Sabel","year":"2015","unstructured":"Sabel MS, Kozminski D, Griffith K, Chang AE, Johnson TM, Wong S. Sentinel lymph node biopsy use among melanoma patients 75 years of age and older. Ann Surg Oncol. 2015;22(7):2112\u20139. https:\/\/doi.org\/10.1245\/s10434-015-4539-7.","journal-title":"Ann Surg Oncol."},{"key":"15684_CR11","doi-asserted-by":"publisher","unstructured":"Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF, et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022;157(9):835-42. https:\/\/doi.org\/10.1001\/jamasurg.2022.2055","DOI":"10.1001\/jamasurg.2022.2055"},{"key":"15684_CR12","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Data, 17 Registries, Nov 2021 Sub (2000-2019) - Linked To County Attributes - Time Dependent (1990-2019) Income\/Rurality, 1969\u20132020 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2022, based on the November 2021 submission."},{"key":"15684_CR13","unstructured":"SRP Communications N. Surveillance Research Program (SRP) Surveillance, Epidemiology and End Results (SEER) Program Metrics. 2020."},{"key":"15684_CR14","unstructured":"Adamo M, Groves C, Dickie L, Ruhl J. (September 2022). SEER Program Coding and Staging Manual 2023. National Cancer Institute, Bethesda, MD 20892. U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute."},{"key":"15684_CR15","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021."},{"issue":"5","key":"15684_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/jnci\/djz153","volume":"112","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, Gudenkauf FJ. Melanoma incidence among non-hispanic whites in all 50 US States from 2001 through 2015. JNCI. 2020;112(5):533\u20139. https:\/\/doi.org\/10.1093\/jnci\/djz153.","journal-title":"JNCI"},{"issue":"3","key":"15684_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1245\/aso.2004.04.015","volume":"11","author":"C Chao","year":"2004","unstructured":"Chao C, Martin RCG, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol. 2004;11(3):259\u201364. https:\/\/doi.org\/10.1245\/aso.2004.04.015.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"15684_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1245\/s10434-013-3464-x","volume":"21","author":"CM Balch","year":"2014","unstructured":"Balch CM, Thompson JF, Gershenwald JE, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014;21(4):1075\u201381. https:\/\/doi.org\/10.1245\/s10434-013-3464-x.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"15684_CR19","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/cncr.23359","volume":"112","author":"K Lasithiotakis","year":"2008","unstructured":"Lasithiotakis K, Leiter U, Meier F, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer. 2008;112(8):1795\u2013804. https:\/\/doi.org\/10.1002\/cncr.23359.","journal-title":"Cancer."},{"issue":"3","key":"15684_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jgo.2018.06.009","volume":"10","author":"E Bastiaannet","year":"2019","unstructured":"Bastiaannet E, Battisti N, Loh KP, et al. Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper. J Geriatr Oncol. 2019;10(3):389\u201397. https:\/\/doi.org\/10.1016\/j.jgo.2018.06.009.","journal-title":"J Geriatr Oncol."},{"issue":"2","key":"15684_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","volume":"43","author":"JA Moody","year":"2017","unstructured":"Moody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma\u2014A systematic review of the literature. Eur J Surg Oncol. 2017;43(2):270\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2016.06.407.","journal-title":"Eur J Surg Oncol."},{"key":"15684_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58111589","author":"DE Br\u0103ni\u015fteanu","year":"2022","unstructured":"Br\u0103ni\u015fteanu DE, Cozmin M, Porumb-Andrese E, et al. Sentinel lymph node biopsy in cutaneous melanoma, a clinical point of view. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina58111589.","journal-title":"Medicina (Kaunas)"},{"key":"15684_CR23","unstructured":"Staheli B, Rondeau B. Anesthetic Considerations in the Geriatric Population. 2024."},{"issue":"3","key":"15684_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cger.2007.03.005","volume":"23","author":"SC Castle","year":"2007","unstructured":"Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007;23(3):463\u201379. https:\/\/doi.org\/10.1016\/j.cger.2007.03.005.","journal-title":"Clin Geriatr Med."},{"issue":"6","key":"15684_CR25","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1245\/s10434-009-0420-x","volume":"16","author":"WC Conway","year":"2009","unstructured":"Conway WC, Faries MB, Nicholl MB, et al. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol. 2009;16(6):1548\u201352. https:\/\/doi.org\/10.1245\/s10434-009-0420-x.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"15684_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34742","volume":"15","author":"DC Sasson","year":"2023","unstructured":"Sasson DC, Smetona JT, Parsaei Y, et al. Malignant melanoma in older adults: different patient or different disease? Cureus. 2023;15(2):e34742. https:\/\/doi.org\/10.7759\/cureus.34742.","journal-title":"Cureus."},{"issue":"12","key":"15684_CR27","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","volume":"17","author":"MB Faries","year":"2010","unstructured":"Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial (I). Ann Surg Oncol. 2010;17(12):3324\u20139. https:\/\/doi.org\/10.1245\/s10434-010-1203-0.","journal-title":"Ann Surg Oncol."},{"issue":"32","key":"15684_CR28","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: No survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000\u20138. https:\/\/doi.org\/10.1200\/JCO.18.02306.","journal-title":"J Clin Oncol."},{"issue":"5\u20136","key":"15684_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10585-018-9898-6","volume":"35","author":"MB Faries","year":"2018","unstructured":"Faries MB, Han D, Reintgen M, Kerivan L, Reintgen D, Carac\u00f2 C. Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. Clin Exp Metastasis. 2018;35(5\u20136):431\u201342. https:\/\/doi.org\/10.1007\/s10585-018-9898-6.","journal-title":"Clin Exp Metastasis."},{"issue":"7823","key":"15684_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2623-z.","journal-title":"Nature."},{"issue":"20","key":"15684_CR31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/jnci\/djq366","volume":"102","author":"N Howlader","year":"2010","unstructured":"Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102(20):1584\u201398. https:\/\/doi.org\/10.1093\/jnci\/djq366.","journal-title":"J Natl Cancer Inst."},{"key":"15684_CR32","doi-asserted-by":"publisher","unstructured":"Forjaz de Lacerda G, Howlader N, Mariotto AB. Differences in cancer survival with relative versus cause-specific approaches: an update using more accurate life tables. Cancer Epidemiol Biomarkers Prev. 2019;28(9):1544-51. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0125","DOI":"10.1158\/1055-9965.EPI-19-0125"},{"issue":"10","key":"15684_CR33","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/cncr.27968","volume":"119","author":"CY Hu","year":"2013","unstructured":"Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer. 2013;119(10):1900\u20137. https:\/\/doi.org\/10.1002\/cncr.27968.","journal-title":"Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15684-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:04:45Z","timestamp":1728569085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["15684"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15684-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURE"}}]}}